Duke Cancer Institute
Background data
Program Type : Adult ProgramFACT Approved: Yes
Year CAR T-cell Therapy Program Opened:
Location Info
Duke Cancer InstituteDuke Blood Cancer Center
2400 Pratt St., Suite 5000
Durham, , 27705
Durham, , 27705
Website : https://www.dukehealth.org/treatments/cancer/adult-bone-marrow-transplant
CAR T-cell therapies performed
Numbers displayed are the most recent data provided by this center.| Year | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Number performed | 35 | 27 | 41 | 75 | - |
Medical Director
| Name | Phone |
|---|---|
| Mitchell Horwitz, MD | (919) 668-1000 |
Physician
| Name | Phone |
|---|---|
| Taewoong Choi, MD | (919) 668-1000 |
| Chenyu Lin, MD | (919) 668-1000 |
| Matthew McKinney, MD | (919) 668-1000 |
| Sendhilnathan Ramalingam, MD | (919) 668-1000 |
| Andrea Sitlinger, MD | (919) 668-1000 |
| Alexandra Stefanovic, MD | (919) 668-1000 |
| Jie Wang, MD | (919) 668-1000 |
Coordinator
| Name | Phone |
|---|---|
| Lauren Jones, RN, BSN, OCN | (919) 668-3432 |
Diseases treated by CAR T-cell therapy
- Leukemia, acute lymphoblastic
- Lymphoma
- Multiple Myeloma
CAR T-Cell products
- Abecma (idecabtagene vicleucil, ide-cel)
- Breyanzi (lisocabtagene maraleucel, liso-cel)
- Carvykti (ciltacabtagene autoleucel, cita-cel)
- Kymriah (tisagenlecleucel, tisa-cel)
- Tecartus (brexucabtagene autoleucel, brexu-cel)
- Yescarta (axicabtagene ciloleucel, axi-cel)